These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 18711175

  • 1. Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study.
    Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG.
    J Clin Oncol; 2008 Oct 10; 26(29):4784-90. PubMed ID: 18711175
    [Abstract] [Full Text] [Related]

  • 2. Acyclovir prophylaxis against varicella zoster virus reactivation in multiple myeloma patients treated with bortezomib-based therapies: a retrospective analysis of 100 patients.
    Swaika A, Paulus A, Miller KC, Sher T, Almyroudis NG, Ball D, Wood M, Masood A, Lee K, Chanan-Khan AA.
    J Support Oncol; 2012 Oct 10; 10(4):155-9. PubMed ID: 22222250
    [Abstract] [Full Text] [Related]

  • 3. Bortezomib and bilateral herpes zoster.
    di Meo N, Bergamo S, Dondas A, Trevisan G.
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Oct 10; 21(1):21-2. PubMed ID: 22584902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients.
    Tong Y, Qian J, Li Y, Meng H, Jin J.
    Am J Hematol; 2007 May 10; 82(5):403-4. PubMed ID: 17133426
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.
    Pour L, Adam Z, Buresova L, Krejci M, Krivanova A, Sandecka V, Zahradova L, Buchler T, Vorlicek J, Hajek R.
    Clin Lymphoma Myeloma; 2009 Apr 10; 9(2):151-3. PubMed ID: 19406726
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma.
    Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, San Miguel JF, Cavenagh JD, Anderson KC.
    Br J Haematol; 2007 Jun 10; 137(5):429-35. PubMed ID: 17451408
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Late onset of bortezomib-associated cutaneous reaction following herpes zoster.
    Varettoni M, Vassallo C, Borroni G, Mangiacavalli S, Zappasodi P, Rosso R, Lazzarino M, Corso A.
    Ann Hematol; 2007 Apr 10; 86(4):301-2. PubMed ID: 17131123
    [No Abstract] [Full Text] [Related]

  • 11. Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma.
    Kim SJ, Kim K, Kim BS, Lee HJ, Kim H, Lee NR, Nam SH, Kwon JH, Kim HJ, Sohn SK, Won JH, Lee JH, Suh C, Yoon SS, Kim HJ, Kim I, Do YR, Lee WS, Joo YD, Shin HJ, Korean Multiple Myeloma Working Party.
    Clin Lymphoma Myeloma; 2008 Aug 10; 8(4):237-40. PubMed ID: 18765311
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?
    Dasanu CA, Alexandrescu DT.
    J Oncol Pharm Pract; 2010 Dec 10; 16(4):266-8. PubMed ID: 19965947
    [Abstract] [Full Text] [Related]

  • 14. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib.
    Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, Singhal S, Siegel DS, Irwin D, Schuster M, Srkalovic G, Alexanian R, Rajkumar SV, Limentani S, Alsina M, Orlowski RZ, Najarian K, Esseltine D, Anderson KC, Amato AA.
    J Clin Oncol; 2006 Jul 01; 24(19):3113-20. PubMed ID: 16754936
    [Abstract] [Full Text] [Related]

  • 15. Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma.
    Lonial S, Richardson PG, San Miguel J, Sonneveld P, Schuster MW, Bladé J, Cavenagh J, Rajkumar SV, Jakubowiak AJ, Esseltine DL, Anderson KC, Harousseau JL.
    Br J Haematol; 2008 Oct 01; 143(2):222-9. PubMed ID: 18713253
    [Abstract] [Full Text] [Related]

  • 16. [Prophylaxis with acyclovir for herpes zoster infection during bortezomib-dexamethasone combination therapy].
    Hasegawa Y, Kawahara F, Nagai H, Hirose T, Imai Y, Ishiguro T, Chou T.
    Rinsho Ketsueki; 2009 Jun 01; 50(6):488-94. PubMed ID: 19571509
    [Abstract] [Full Text] [Related]

  • 17. Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib.
    Heider U, Rademacher J, Kaiser M, Kleeberg L, von Metzler I, Sezer O.
    Clin Lymphoma Myeloma Leuk; 2010 Apr 01; 10(2):134-7. PubMed ID: 20371447
    [Abstract] [Full Text] [Related]

  • 18. Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
    Richardson PG, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Bladé J, Boccadoro M, Cavenagh JD, Boral AL, Esseltine DL, Wen PY, Amato AA, Anderson KC, San Miguel J.
    Br J Haematol; 2009 Mar 01; 144(6):895-903. PubMed ID: 19170677
    [Abstract] [Full Text] [Related]

  • 19. [Effects of bortezomib at different doses in combination with dexamethasone in treatment of relapsed or refractory multiple myeloma: a comparative study].
    Bao L, Lu XJ, Zhang XH, Huang XJ.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 08; 88(26):1829-31. PubMed ID: 19040018
    [Abstract] [Full Text] [Related]

  • 20. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
    Zheng W, Wei G, Ye X, He J, Li L, Wu W, Shi J, Zhang J, Huang W, Xie W, Luo Y, Xue X, Lin M, Huang H, Cai Z.
    Leuk Res; 2009 Dec 08; 33(12):1615-8. PubMed ID: 19773080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.